![Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan, Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan,](https://journals.sagepub.com/cms/10.1177/0004563219894354/asset/images/large/10.1177_0004563219894354-fig1.jpeg)
Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan,
![Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01180-x/MediaObjects/41375_2021_1180_Fig1_HTML.png)
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
![Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0399/asset/graphic/j_cclm-2021-0399_fig_001.jpg)
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
![Plasma cell myeloma expressing IgG heavy chain with co-expression of... | Download Scientific Diagram Plasma cell myeloma expressing IgG heavy chain with co-expression of... | Download Scientific Diagram](https://www.researchgate.net/publication/281513243/figure/fig4/AS:931509057896449@1599100474239/Plasma-cell-myeloma-expressing-IgG-heavy-chain-with-co-expression-of-kappa-and-lambda.png)
Plasma cell myeloma expressing IgG heavy chain with co-expression of... | Download Scientific Diagram
![Figure 1 from IgD-kappa multiple myeloma. Case report and brief review of the literature | Semantic Scholar Figure 1 from IgD-kappa multiple myeloma. Case report and brief review of the literature | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f79a2c2d60e04a3f09b1e3615ba2dd6a0a0efc9f/2-Figure1-1.png)
Figure 1 from IgD-kappa multiple myeloma. Case report and brief review of the literature | Semantic Scholar
![What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms](https://i1.wp.com/www.differencebetween.com/wp-content/uploads/2022/03/Four_Chain_Structure_of_a_Generic_Antibody-IgG2_Structures.jpg?resize=553%2C220&ssl=1)
What is the Difference Between Kappa and Lambda Light Chains | Compare the Difference Between Similar Terms
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)